David Shaw’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-124,432
| Closed | -$562K | – | 4632 |
|
|
2025
Q4 | $562K | Sell |
124,432
-23,852
| -16% | -$122K | ﹤0.01% | 3871 |
|
|
2025
Q3 | $799K | Sell |
148,284
-58,071
| -28% | -$314K | ﹤0.01% | 3600 |
|
|
2025
Q2 | $1.12M | Buy |
+206,355
| New | +$818K | ﹤0.01% | 3157 |
|
|
2025
Q1 | – | Sell |
-19,394
| Closed | -$66.1K | – | 4346 |
|
|
2024
Q4 | $66.1K | Buy |
+19,394
| New | +$55.9K | ﹤0.01% | 4194 |
|
|
2024
Q2 | – | Sell |
-495,780
| Closed | -$1.5M | – | 4542 |
|
|
2024
Q1 | $1.5M | Buy |
495,780
+218,242
| +79% | +$766K | ﹤0.01% | 2824 |
|
|
2023
Q4 | $1.17M | Buy |
+277,538
| New | +$1.51M | ﹤0.01% | 3038 |
|
|
2023
Q1 | – | Sell |
-115,726
| Closed | -$698K | – | 4529 |
|
|
2022
Q4 | $698K | Buy |
115,726
+60,896
| +111% | +$450K | ﹤0.01% | 3666 |
|
|
2022
Q3 | $432K | Sell |
54,830
-28,523
| -34% | -$333K | ﹤0.01% | 4120 |
|
|
2022
Q2 | $1.13M | Buy |
83,353
+70,991
| +574% | +$1.17M | ﹤0.01% | 3548 |
|
|
2022
Q1 | $242K | Buy |
12,362
+5,121
| +71% | +$102K | ﹤0.01% | 4763 |
|
|
2021
Q4 | $248K | Sell |
7,241
-9,372
| -56% | -$377K | ﹤0.01% | 4775 |
|
|
2021
Q3 | $907K | Sell |
16,613
-1,396
| -8% | -$84.1K | ﹤0.01% | 3684 |
|
|
2021
Q2 | $1.32M | Buy |
+18,009
| New | +$1.8M | ﹤0.01% | 3315 |
|
|
2021
Q1 | – | Sell |
-83,337
| Closed | -$6.76M | – | 4119 |
|
|
2020
Q4 | $6.76M | Buy |
+83,337
| New | +$6.38M | 0.01% | 1647 |
|
David Shaw's CVAC Position: Q1 2026 in Review
David Shaw sold out of CureVac (CVAC) in Q1 2026, closing a stake of 124,432 shares — an estimated $562K sold.
David Shaw first reported a position in CVAC in Q4 2020 and held it in 14 quarters. The position peaked at $6.76M in Q4 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- David Shaw reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- David Shaw sold 124,432 CureVac shares in Q1 2026, an estimated $562K.
- David Shaw first reported a position in CureVac in Q4 2020 and held it in 14 quarters.
- David Shaw's CureVac position peaked at $6.76M in Q4 2020.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.